Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.60    -2.60 (-2.52%)
Bid:
101.00
Ask:
101.80
Spread: 0.80 (0.792%)
Market Cap: £164.93m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

1 May 2014 07:00

RNS Number : 0132G
Synthomer PLC
01 May 2014
Β 

ο»Ώ

1st May 2014

Β 

Synthomer plc

Β 

AGM and Interim Management Statement

Β 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 January to 30 April 2014.

Β 

Trading

Β 

We reported with our full year results in February that we had experienced slightly firmer demand in Europe across our Construction & Coatings, Functional Polymers and Performance Polymers segments. Encouragingly, this trend has continued, and as a result operating profit for the first quarter in our Europe and North America business (ENA) was ahead of the prior year, despite an adverse currency translation impact of Β£0.6M.

Β 

In our Asia and Rest of the World (ARW) business, volumes have continued to progress. However, recent substantial expansions by nitrile customers has led to excess glove capacity and aggressive competition between glove manufacturers. Combined with falling Butadiene prices this has resulted in destocking and short term pressure on nitrile margins. However, we expect on-going demand growth for nitrile latex and unit margins to firm as the year progresses.

Β 

The Group is currently developing plans for a further expansion of nitrile latex capacity, and expects to make an announcement in the next few months

Β 

Financial Position

Β 

Net debt increased over the first three months in line with normal seasonality. The Board has previously indicated it would move dividend cover to three times by 2015. However, in the light of the Group's current low leverage, and strong underlying cash flow generation, the Board is reviewing that policy with a view to increasing the planned level of returns to shareholders. Any revised dividend policy will be formally communicated to shareholders with the interim results.

Β 

Outlook

Whilst the start to the year in Europe has been encouraging, we remain cautious until these trends become more sustained. So far in 2014, Asia has performed below our expectations due to the competitive environment in the glove market. Although the overall Asia and ROW results may now be slightly weaker than our expectations at the start of the year, we believe the fundamental drivers for our business in the region remain strong.

Β 

The Board remains confident in the medium and long term outlook for the Group.

Β 

Synthomer will announce its Interim Results on Monday 11th August 2014.

Β 

Enquiries:

Β 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

The company will host a conference call for analysts at 8.00am (BST) today:

Β 

Dial-In: +44 203 426 2845Β 

Please quoteΒ "Synthomer" to gain access to the call

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSURAORSVASOUR
Date   Source Headline
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement
22nd Oct 20143:00 pmRNSAcquisition
17th Oct 20141:03 pmRNSDirector/PDMR Shareholding
16th Oct 20143:56 pmRNSDirector/PDMR Shareholding
15th Oct 201412:35 pmRNSDirector/PDMR Shareholding
14th Oct 20142:40 pmRNSDirector/PDMR Shareholding
13th Oct 20149:35 amRNSDirector Declaration
11th Aug 20147:00 amRNSInterim Results
11th Jul 20147:00 amRNSTrading update
1st Jul 20147:00 amRNSAdrian Whitfield to step down as CEO
23rd Jun 201412:01 pmRNSHolding(s) in Company
30th May 20149:24 amRNSHolding(s) in Company
15th May 20144:26 pmRNSDirector/PDMR Shareholding
8th May 201411:25 amRNSDirector/PDMR Shareholding
7th May 20144:35 pmRNSDirector/PDMR Shareholding
1st May 20142:47 pmRNSResult of AGM
1st May 20147:00 amRNSInterim Management Statement
14th Apr 20149:23 amRNSHolding(s) in Company
9th Apr 20143:08 pmRNSHolding(s) in Company
9th Apr 201411:26 amRNSHolding(s) in Company
31st Mar 20149:40 amRNSAnnual Financial Report
14th Mar 20144:17 pmRNSHolding(s) in Company
14th Mar 201411:48 amRNSHolding(s) in Company
12th Mar 20142:40 pmRNSDirector/PDMR Shareholding
6th Mar 20144:15 pmRNSDirector/PDMR Shareholding
6th Mar 20144:12 pmRNSDirector/PDMR Shareholding
5th Mar 20147:00 amRNSChanges to Board Committees
4th Mar 20142:14 pmRNSHolding(s) in Company
28th Feb 20147:01 amRNSPreliminary Results
13th Feb 20142:57 pmRNSHolding(s) in Company
16th Jan 20148:53 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSDirectorate Change
6th Dec 20139:34 amRNSHolding(s) in Company
22nd Nov 20134:08 pmRNSHolding(s) in Company
20th Nov 201311:45 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSCapital Markets Day
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.